Poland’s health ministry has added 70 new drugs to the reimbursed medicines list, effective March 1. The list includes three medicines containing active substances previously not subject to reimbursement — penicillamine for the treatment of Wilson’s disease, ethambutol for tuberculosis and conestat alpha for the prevention of hereditary angioedema attacks.
International Pharmaceutical Regulatory Monitor